Revvity, 3222-002B, Vanadis Core Reagent Cartridge II
Vanadis Core™ qualitative assay for screening the risk of trisomy 21, 18, 13 and sex chromosome aneuploidies in fetal cell-free DNA from pregnant women ≥10 weeks gestation. Uses rolling circle amplification technology for automated processing of up to 84 samples with high detection rates and low false positives. Vanadis Core™ qualitative assay for screening the risk of trisomy 21, 18, 13 and sex chromosome aneuploidies in fetal cell-free DNA from pregnant women ≥10 weeks gestation. Uses rolling
Catalog Number: 3222-002B



